AXON: AI And Drones Will Extend Public Safety Market Reach

Axon Enterprise's analyst fair value estimate has inched lower from $822.50 to $815.00 as analysts factor in mixed Q3 orders, a slightly higher discount rate, and a blend of cautious and constructive views reflected in recent price target changes ranging from $610 to $860.

Analyst Commentary

Recent research highlights a split between bullish analysts focused on Axon Enterprise's longer term growth path and more cautious voices reacting to mixed Q3 orders and valuation questions.

Bullish Takeaways

Some bullish analysts see Axon as well positioned in what they describe as a large and growing addressable market, which they view as supportive of higher long term revenue potential.
One major firm points to 25% revenue growth as something it expects to continue, citing cross sell and up sell opportunities within the U.S. state and local public safety market.
Expansion into new customer groups and product categories is viewed as a key growth lever that could, in their view, help justify price targets clustered in the US$742 to US$860 range.
Supportive analysts argue that the mix of hardware, software, and cloud based services gives Axon a recurring revenue profile that, if executed well, can support premium valuation multiples.

Bearish Takeaways

Bearish analysts highlight the mixed Q3, pointing to weaker than expected orders even as the overall business outlook is described as strong, which raises questions about near term execution risk.
The cut in at least one price target to US$610 from US$840 reflects caution about paying higher multiples while order trends and discount rate assumptions are under review.
Some cautious views center on whether Axon can consistently convert its broader market opportunity and product expansion into sustained growth without periodic volatility in bookings.
There is also concern that if revenue growth moderates versus the 25% level cited by one firm, current valuation expectations could be harder to support.

What's in the News

Axon Enterprise raised full year 2025 revenue guidance to approximately US$2.74b, compared with prior guidance of US$2.65b to US$2.73b, which the company states represents approximately 31% annual growth (Corporate guidance).
The company issued revenue guidance for the fourth quarter of 2025 in the range of US$750 million to US$755 million, which it states represents approximately 31% year over year growth (Corporate guidance).
Between July 1, 2025 and September 30, 2025, Axon Enterprise repurchased 0 shares for US$0 under its existing buyback and reported that, since the program announced on February 29, 2016, it has completed the repurchase of 1,788,069 shares for US$33.8 million, or 3.35% of shares (Buyback update).

Valuation Changes

Fair Value Estimate was trimmed slightly from US$822.50 to US$815.00 per share.
The Discount Rate moved modestly higher from 7.60% to about 7.64%.
The Revenue Growth Assumption remains effectively unchanged at about 25.09%.
The Net Profit Margin Assumption remains effectively unchanged at about 7.34%.
The Future P/E Multiple edged lower from about 239.7x to about 237.8x.

78 views

Key Takeaways

Adoption of advanced tech and premium bundled SaaS offerings is boosting customer value, margins, and recurring revenue growth as agencies modernize and upgrade.
Global expansion and rising public safety challenges are broadening the addressable market, supporting growth and reducing reliance on any single region or product.
Dependence on government funding, regulatory scrutiny, rising competition, international risks, and increasing costs threaten stability, margin strength, and global growth prospects.

Catalysts

About Axon Enterprise

Develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally.What are the underlying business or industry changes driving this perspective?

Accelerating demand for next-generation technologies-including AI, drones, robotics, body cameras, and digital evidence management-demonstrates a rapid shift by public safety agencies toward modern, cloud-based, and connected solutions; this supports sustained revenue growth as agencies upgrade from legacy systems and adopt more comprehensive SaaS offerings.
Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer, raising net revenue per user and supporting higher long-term margins as the ecosystem deepens.
International expansion, highlighted by record deals in regions like Africa and growing traction in Europe, LATAM, and Asia, are broadening Axon's global addressable market and diversifying revenue streams, which is expected to accelerate aggregate top-line growth and reduce revenue volatility over time.
Increasing public safety challenges (e.g., civil unrest, immigration pressures, drone threats) are prompting governments to invest more in non-lethal defense technologies and digital collaboration platforms, creating durable tailwinds for Axon's integrated product suite and underpinning both bookings growth and future recurring revenue.
The ongoing shift by public safety agencies from basic contracts to premium plans and AI-enabled bundles, together with a large installed base yet to upgrade, offers a clear multi-year upsell runway that is likely to drive growing net revenue retention, expansion of recurring SaaS revenues, and higher overall earnings.

Axon Enterprise Earnings and Revenue Growth

Axon Enterprise Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Axon Enterprise's revenue will grow by 24.3% annually over the next 3 years.
Analysts assume that profit margins will shrink from 13.6% today to 10.4% in 3 years time.
Analysts expect earnings to reach $476.0 million (and earnings per share of $4.72) by about September 2028, up from $326.3 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $951.7 million in earnings, and the most bearish expecting $330.1 million.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 197.2x on those 2028 earnings, up from 176.1x today. This future PE is greater than the current PE for the US Aerospace & Defense industry at 34.4x.
Analysts expect the number of shares outstanding to grow by 2.95% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.67%, as per the Simply Wall St company report.

Axon Enterprise Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Heavy reliance on government contracts and budgets, which are inherently vulnerable to political changes, funding cycles, and shifting public sentiment about law enforcement resources, could lead to revenue volatility and impact long-term earnings growth.
Increased public scrutiny, regulatory, and privacy concerns over surveillance and law enforcement technology (such as body cameras and AI-powered analytics) could prompt stricter legislation or limitations, potentially hampering the adoption of Axon's key products and limiting recurring SaaS revenue expansion.
Growing competition from both established defense technology players and innovative startups, particularly in high-margin areas like AI analytics, drones, and evidence management, poses a risk to Axon's pricing power and margin sustainability.
Exposure to international market expansion risk, including potential shifts in government procurement favoring local/domestic suppliers or rapidly changing regulatory environments, may inhibit Axon's global growth ambitions and prevent meaningful revenue diversification.
Ongoing increases in tariffs, manufacturing costs, and potential product liability risks (highlighted by concerns over misuse of Axon hardware or software) could compress gross and net margins, escalating operational and legal costs and reducing long-term profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $884.692 for Axon Enterprise based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $1000.0, and the most bearish reporting a price target of just $800.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $4.6 billion, earnings will come to $476.0 million, and it would be trading on a PE ratio of 197.2x, assuming you use a discount rate of 7.7%.
Given the current share price of $731.98, the analyst price target of $884.69 is 17.3% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Axon Enterprise?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.